PRECIGEN, INC. — Director's Dealing 2022

Oct 11, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2022-10-01

Reporting Person: Shah Rutul R (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	52895	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock (Right to Buy)	$17.34	2024-09-04	Common Stock (4944)		Direct
Option to Purchase Common Stock (Right to Buy)	$45.69	2025-03-12	Common Stock (2597)		Direct
Option to Purchase Common Stock (Right to Buy)	$34.85	2026-03-10	Common Stock (2510)		Direct
Option to Purchase Common Stock (Right to Buy)	$21.38	2027-03-16	Common Stock (5000)		Direct
Option to Purchase Common Stock (Right to Buy)	$15.80	2028-03-23	Common Stock (4000)		Direct
Option to Purchase Common Stock (Right to Buy)	$8.60	2029-06-18	Common Stock (40000)		Direct
Option to Purchase Common Stock (Right to Buy)	$4.67	2030-07-16	Common Stock (60000)		Direct
Option to Purchase Common Stock (Right to Buy)	$8.17	2031-04-21	Common Stock (100000)		Direct
Option to Purchase Common Stock (Right to Buy)	$2.33	2032-02-02	Common Stock (200000)		Direct

Footnotes

F1: The stock options are fully vested.

F2: 30,000 of the stock options are fully vested. The remaining stock options vest on June 18, 2023.

F3: 30,000 of the stock options are fully vested. The remaining stock options vest in equal installments on each of July 16, 2023 and July 16, 2024.

F4: 25,000 of the stock options are fully vested. The remaining stock options vest in equal installments on each of April 21, 2023, April 21, 2024 and April 21, 2025.

F5: These stock options vest in equal installments on each of February 2, 2023, February 2, 2024, February 2, 2025 and February 2, 2026.